SENSUS HEALTHCARE INC (SRTS) Stock Price & Overview

NASDAQ:SRTS • US81728J1097

4.41 USD
-0.2 (-4.34%)
Last: Mar 4, 2026, 08:00 PM

The current stock price of SRTS is 4.41 USD. Today SRTS is down by -4.34%. In the past month the price decreased by -14.86%. In the past year, price decreased by -4.13%.

SRTS Key Statistics

52-Week Range3.03 - 5.92
Current SRTS stock price positioned within its 52-week range.
1-Month Range3.55 - 5.29
Current SRTS stock price positioned within its 1-month range.
Market Cap
72.456M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.47
Dividend Yield
N/A

SRTS Stock Performance

Today
-4.34%
1 Week
+10.53%
1 Month
-14.86%
3 Months
+13.08%
Longer-term
6 Months +36.53%
1 Year -4.13%
2 Years +16.05%
3 Years -15.36%
5 Years +15.14%
10 Years N/A

SRTS Stock Chart

SENSUS HEALTHCARE INC / SRTS Daily stock chart

SRTS Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to SRTS. When comparing the yearly performance of all stocks, SRTS turns out to be only a medium performer in the overall market: it outperformed 50.17% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
SRTS Full Technical Analysis Report

SRTS Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SRTS. No worries on liquidiy or solvency for SRTS as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SRTS Full Fundamental Analysis Report

SRTS Earnings

On February 12, 2026 SRTS reported an EPS of -0.19 and a revenue of 4.94M. The company missed EPS expectations (-166.11% surprise) and missed revenue expectations (-41.98% surprise).

Next Earnings DateMay 13, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported-$0.19
Revenue Reported4.939M
EPS Surprise -166.11%
Revenue Surprise -41.98%
SRTS Earnings History

SRTS Forecast & Estimates

9 analysts have analysed SRTS and the average price target is 6.8 USD. This implies a price increase of 54.2% is expected in the next year compared to the current price of 4.41.

For the next year, analysts expect an EPS growth of 86.98% and a revenue growth 15.07% for SRTS


Analysts
Analysts82.22
Price Target6.8 (54.2%)
EPS Next Y86.98%
Revenue Next Year15.07%
SRTS Forecast & Estimates

SRTS Groups

Sector & Classification

SRTS Financial Highlights

Over the last trailing twelve months SRTS reported a non-GAAP Earnings per Share(EPS) of -0.47. The EPS decreased by -217.5% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-3.01M
Industry RankSector Rank
PM (TTM) N/A
ROA -5.16%
ROE -5.87%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-311.11%
Sales Q2Q%-62.2%
EPS 1Y (TTM)-217.5%
Revenue 1Y (TTM)N/A
SRTS financials

SRTS Ownership

Ownership
Inst Owners29.14%
Shares16.43M
Float13.43M
Ins Owners17.9%
Short Float %3.83%
Short Ratio4.91
SRTS Ownership

SRTS Latest News, Press Relases and Analysis

All SRTS news

SRTS Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.7196.666B
ISRG INTUITIVE SURGICAL INC49.03177.984B
SYK STRYKER CORP25.26146.042B
BSX BOSTON SCIENTIFIC CORP20.62107.089B
IDXX IDEXX LABORATORIES INC43.7851.799B
EW EDWARDS LIFESCIENCES CORP28.6649.453B
BDX BECTON DICKINSON AND CO10.8848.859B
RMD RESMED INC21.137.738B
GEHC GE HEALTHCARE TECHNOLOGY15.7336.013B
DXCM DEXCOM INC28.8728.433B
ZBH ZIMMER BIOMET HOLDINGS INC11.1818.976B
PODD INSULET CORP38.3117.087B
HOLX HOLOGIC INC15.0416.893B

About SRTS

Company Profile

SRTS logo image Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.

Company Info

SENSUS HEALTHCARE INC

851 Broken Sound Pkwy NW Ste 215

Boca Raton FLORIDA 33487 US

CEO: Joseph C. Sardano

Employees: 54

SRTS Company Website

SRTS Investor Relations

Phone: 13023513367

SENSUS HEALTHCARE INC / SRTS FAQ

What does SENSUS HEALTHCARE INC do?

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.


What is the stock price of SENSUS HEALTHCARE INC today?

The current stock price of SRTS is 4.41 USD. The price decreased by -4.34% in the last trading session.


Does SRTS stock pay dividends?

SRTS does not pay a dividend.


What is the ChartMill technical and fundamental rating of SRTS stock?

SRTS has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the PE ratio for SRTS stock?

SENSUS HEALTHCARE INC (SRTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.47).


Can you provide the number of employees for SENSUS HEALTHCARE INC?

SENSUS HEALTHCARE INC (SRTS) currently has 54 employees.


Can you provide the market cap for SENSUS HEALTHCARE INC?

SENSUS HEALTHCARE INC (SRTS) has a market capitalization of 72.46M USD. This makes SRTS a Micro Cap stock.